Medtronic Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023	Apr '22 Apr 29, 2022
Net Income	4,837	4,691	3,705	3,784	5,062
Depreciation & Amortization	2,958	2,861	2,647	2,697	2,707
Stock-Based Compensation	457	429	393	355	359
Other Adjustments	501	117	526	170	107
Change in Receivables	-200	-433	-391	-576	-477
Changes in Inventories	-404	-292	-139	-939	-560
Changes in Accounts Payable	46	209	391	696	213
Changes in Other Operating Activities	-865	-538	-345	-148	-65
Operating Cash Flow	7,330	7,044	6,787	6,039	7,346
Operating Cash Flow Growth	4.06%	3.79%	12.39%	-17.79%	17.72%
Capital Expenditures	-1,904	-1,859	-1,587	-1,459	-1,368
Purchases of Investments	-8,725	-8,226	-7,748	-7,514	-9,882
Proceeds from Sale of Investments	8,105	8,495	7,441	7,343	9,692
Payments for Business Acquisitions	-406	-98	-211	-1,867	-91
Other Investing Activities	-4	-249	-261	4	-10
Investing Cash Flow	-2,934	-1,937	-2,366	-3,493	-1,659
Short-Term Debt Issued	-	-	-	2,284	-
Short-Term Debt Repaid	-	-	-	-2,279	-
Net Short-Term Debt Issued (Repaid)	-	-	-	5	-
Long-Term Debt Issued	1,747	3,209	-	5,409	-
Long-Term Debt Repaid	-2,930	-	-	-6,012	-1
Net Long-Term Debt Issued (Repaid)	-1,183	3,209	-	-603	-1
Issuance of Common Stock	516	508	284	308	429
Repurchase of Common Stock	-1,035	-3,235	-2,138	-645	-2,544
Net Common Stock Issued (Repurchased)	-519	-2,727	-1,854	-337	-2,115
Common Dividends Paid	-3,639	-3,589	-3,666	-3,616	-3,383
Other Financing Activities	591	-1,254	1,070	-409	163
Financing Cash Flow	-4,751	-4,361	-4,450	-4,960	-5,336
Effect of Exchange Rate Changes on Cash and Cash Equivalents	85	188	-230	243	-231
Net Cash Flow	-269	934	-259	-2,171	121
Free Cash Flow	5,426	5,185	5,200	4,580	5,978
Free Cash Flow Growth	4.65%	-0.29%	13.54%	-23.39%	22.38%
FCF Margin	14.92%	15.46%	16.07%	14.67%	18.87%
Free Cash Flow Per Share	4.21	4.02	3.91	3.44	4.42
Levered Free Cash Flow	3,449	8,252	4,643	4,007	5,965
Unlevered Free Cash Flow	4,929	5,346	4,906	4,716	6,204

SEC Filings: 10-K · 10-Q